Uemura, Hirotsugu http://orcid.org/0000-0002-3665-9523
Uemura, Hiroji
Nagamori, Satsohi
Wakumoto, Yoshiaki
Kimura, Go
Kikukawa, Hiroaki
Yokomizo, Akira
Mizokami, Atsushi
Kosaka, Takeo
Masumori, Naoya
Kawasaki, Yoshihide
Yonese, Junji
Nasu, Yasutomo
Fukasawa, Satoshi
Sugiyama, Takayuki
Kinuya, Seigo
Hosono, Makoto
Yamaguchi, Iku
Akagawa, Takashi
Matsubara, Nobuaki
Funding for this research was provided by:
Bayer Yakuhin, Ltd.
Article History
Received: 26 August 2018
Accepted: 24 December 2018
First Online: 14 March 2019
Compliance with ethical standards
:
: The authors have the following conflicts of interest to disclose: Hirotsugu Uemura has received research funding from Astra Zeneca, Sanofi, Janssen, Takeda and Astellas, honoraria from Bayer, Astra Zeneca, Takeda, Sanofi, Janssen and Astellas, and has acted as an advisory to Sanofi, Janssen, and Bayer. Hiroji Uemura has received research funding from Astellas, honoraria from Bayer, Fuji Film RI Pharma, Janssen, Sanofi, Astellas, Takeda, Kissei, and has acted as an advisory to Bayer, Sanofi, Janssen, Takeda and Astellas. Satoshi Nagamori has received research funding from Takeda, Astellas, Taiho and Nihon-Kayaku, honoraria from Bayer, Sanofi, Daiichi-Sankyou and Kirin, and travel fee from Bayer. Go Kimura has received honoraria from Novartis, Pfizer and Bayer. Atsushi Mizokami has received honoraria from Bayer. Naoya Masumori has received research funding from Shionogi, Chugai, MSD, Taiho, Ono, Aska, Nippon Shinyaku, Takeda and Daiichi Sankyo, and honoraria from Bayer, Daiichi-Sankyo, GSK, Takeda, Nippon-Shinyaku, Pfizer, Astellas, Astra Zeneca, Kissei, Kyorin, Janssen and Vorpal Technologies. Yasutomo Nasu owns stock of Momotaro-Gene Inc. Seigo Kinuya has received honoraria from Bayer. Iku Yamaguchi and Takashi Akagawa are employees of Bayer Yakuhin Ltd. Nobuaki Matsubara has received research funding from Bayer. All remaining authors declared no conflict of interest.